| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
223,469 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,468,702 |
|
|
|
Indirect Value
|
$3,772,028 |
|
|
| Total
Shares |
3,384,944 |
|
|
| Total
Value |
$6,240,730 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-06 |
4,655 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
423 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-07-08 |
4 |
AS |
$66.55 |
$347,779 |
I/I |
(5,000) |
156,554 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2016-11-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
12,350 |
165,575 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-12-10 |
4 |
S |
$4.88 |
$48,814 |
I/I |
(10,000) |
177,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2012-11-23 |
4 |
B |
$1.40 |
$138,481 |
I/I |
99,000 |
179,000 |
2.1 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-12-09 |
4 |
S |
$4.81 |
$48,122 |
I/I |
(10,000) |
187,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-11-24 |
4 |
S |
$5.10 |
$51,024 |
I/I |
(10,000) |
197,925 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-01-03 |
4 |
AS |
$22.82 |
$176,316 |
I/I |
(7,704) |
199,539 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-12-01 |
4 |
AS |
$23.95 |
$184,503 |
I/I |
(7,704) |
207,243 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-11-23 |
4 |
S |
$4.96 |
$148,923 |
I/I |
(30,000) |
207,925 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-11-01 |
4 |
AS |
$25.43 |
$196,386 |
I/I |
(7,704) |
214,947 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-10-03 |
4 |
AS |
$26.77 |
$209,296 |
I/I |
(7,704) |
222,651 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-09-01 |
4 |
AS |
$28.08 |
$216,328 |
I/I |
(7,704) |
230,355 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-09-16 |
4 |
S |
$4.91 |
$49,079 |
I/I |
(10,000) |
237,925 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-08-01 |
4 |
AS |
$27.47 |
$211,629 |
I/I |
(7,704) |
238,059 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-04-26 |
4 |
A |
$0.00 |
$0 |
I/I |
60,997 |
246,249 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-09-15 |
4 |
S |
$5.00 |
$50,045 |
I/I |
(10,000) |
247,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-08-27 |
4 |
S |
$4.99 |
$49,900 |
I/I |
(10,000) |
257,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-08-26 |
4 |
S |
$4.54 |
$45,351 |
I/I |
(10,000) |
267,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-07-21 |
4 |
S |
$4.98 |
$49,800 |
I/I |
(10,000) |
277,925 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-07-20 |
4 |
S |
$5.32 |
$53,200 |
I/I |
(10,000) |
287,925 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-04-22 |
4 |
AS |
$63.65 |
$486,658 |
I/I |
(7,500) |
290,993 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2015-06-24 |
4 |
S |
$6.57 |
$65,700 |
I/I |
(10,000) |
297,925 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-04-21 |
4 |
AS |
$59.20 |
$468,637 |
I/I |
(7,500) |
298,493 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2014-05-09 |
4 |
B |
$1.79 |
$224,213 |
I/I |
125,000 |
304,000 |
2.1 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-04-07 |
4 |
AS |
$70.62 |
$537,777 |
I/I |
(7,500) |
305,993 |
0 |
- |
|
423 Records found
|
|
Page 15 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
